Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus

Cancer Biology and Therapy

Volumn 8, Issue 16, 2009, Pages 1527-1533

  Kolb, Armin ^a   Rieder, Simon ^a   Born, Diana ^a   Giese, Nathalia A ^a   Giese, Thomas ^a   Rudofsky, Gottfried ^a   Werner, Jens ^a   Büchler, Markus W ^a   Friess, Helmut ^b   Esposito, Irene ^c,d   Kleeff, Jörg ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Biomarker; Diabetes mellitus; Diagnosis; Glucagon; Insulin; Pancreatic cancer; Screening

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GLUCAGON BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ADENOCARCINOMA; PANCREAS ISLET; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS CARCINOMA; PANCREAS TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 78651271840     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.16.9006     Document Type: Article

References (29)

1. Chow WH, Gridley G, Nyren O, Linet MS, Ekbom A, Fraumeni JF Jr, et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. Journal of the National Cancer Institute 1995; 87:930-931
2. Cuzick J, Babiker AG. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. International journal of cancer 1989; 43:415-421 (Pubitemid 19092322)
3. Ragozzino M, Melton LJ, 3rd, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. Journal of chronic diseases 1982; 35:13-19 (Pubitemid 12213476)
4. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. Journal of the National Cancer Institute 1998; 90:1710-1719 (Pubitemid 28539090)
5. Gullo L, Pezzilli R, Morselli-Labate AM. Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group. The New England journal of medicine 1994; 331:81-84
6. Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 2006; 15:1458-1463 (Pubitemid 44299315)
7. Yalniz M, Pour PM. Diabetes mellitus: a risk factor for pancreatic cancer? Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie 2005; 390:66-72.
8. Gupta S, Vittinghoff E, Bertenthal D, Corley D, Shen H, Walter LC, et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 2006; 4:1366-1372
9. Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 2005; 129:504-511 (Pubitemid 41096638)
10. Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer research 1994; 14:2827-2830
11. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J. Pancreatic cancer is associated with impaired glucose metabolism. The European journal of surgery = Acta chirurgica 1993; 159:101-107 (Pubitemid 23112386)
12. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008; 134:95-101. (Pubitemid 350309328)
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 1:5-19.
14. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. The British journal of surgery 1993; 80:1047-1050 (Pubitemid 23261595)
15. Basso D, Plebani M, Fogar P, Del Favero G, Briani G, Meggiato T, et al. Beta-cell function in pancreatic adenocarcinoma. Pancreas 1994; 9:332-335
16. Fogar P, Basso D, Panozzo MP, Del Favero G, Briani G, Fabris C, et al. C-peptide pattern in patients with pancreatic cancer. Anticancer research 1993; 13:2577-2580 (Pubitemid 24103309)
17. Permert J, Larsson J, Fruin AB, Tatemoto K, Herrington MK, von Schenck H, et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997; 15:60-68 (Pubitemid 27527361)
18. Pour PM, Permert J, Mogaki M, Fujii H, Kazakoff K. Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance. American journal of clinical pathology 1993; 100:223-230 (Pubitemid 23268647)
19. Schwartz SS, Zeidler A, Moossa AR, Kuku SF, Rubenstein AH. A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. The American journal of digestive diseases 1978; 23:1107-1114 (Pubitemid 9100440)
20. Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? Clinica chimica acta; international journal of clinical chemistry 2006; 372:120-128 (Pubitemid 44286765)
21. Katsumichi I, Pour PM. Diabetes mellitus in pancreatic cancer: is it a causal relationship? Am J Surg 2007; 194:71-75
22. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA: a cancer journal for clinicians 2008; 58:71-96.
23. Loos M, Kleeff J, Friess H, Buchler MW. Approaches to localized pancreatic cancer. Curr Oncol Rep 2008; 10:212-219
24. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. The lancet oncology 2009; 10:88-95.
25. Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, Ramesh H, et al. Mast cell distribution and activation in chronic pancreatitis. Hum Pathol 2001; 32:1174-1183 (Pubitemid 33104427)
26. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008; 134:981-987
27. Michaelis D, Jutzi E, Albrecht G. Prevalence and incidence trends of non-insulin-dependent diabetes mellitus (NIDDM) in the population of the GDR. Dtsch Z Verdau Stoffwechselkr 1987; 47:301-310
28. Vilbergsson S, Sigurdsson G, Sigvaldason H, Hreidarsson AB, Sigfusson N. Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-1991 - the Reykjavik Study. Diabet Med 1997; 14:491-498
29. SEER Cancer Statistic Review - Cancer Statistic Review, 1975-2005. 2008.